Research Article
MicroRNA-146a Serves as a Biomarker for Adverse Prognosis of ST-Segment Elevation Myocardial Infarction
Table 1
Baseline characteristics of all study participants.
| Variable | Control () | STEMI () | value |
| Age, years | | | 0.689 | Gender (, %) | | | 0.315 | Male | 64 (64.00%) | 134 (69.79%) | | Female | 36 (36.00%) | 58 (30.21%) | | Hypertension (, %) | | | 0.346 | No | 66 (66.00%) | 137 (71.35%) | | Yes | 34 (34.00%) | 55 (28.65%) | | Diabetes mellitus (, %) | | | 0.284 | No | 82 (82.00%) | 147 (76.56%) | | Yes | 18 (18.00%) | 45 (23.44%) | | Smoke (, %) | | | 0.243 | No | 82 (82.00%) | 146 (76.04%) | | Yes | 18 (18.00%) | 46 (23.96%) | | BMI, kg/m2 | | | <0.001 | WBC, ×109/L | | | <0.001 | Hemoglobin, g/L | | | 0.011 | hs-CRP, mg/L | | | <0.001 | HDL-C, mmol/L | | | <0.001 | LDL-C, mmol/L | | | 0.67 | Total cholesterol, mmol/L | | | 0.013 | Triglyceride, mmol/L | | | 0.479 | LDH, U/L | | | <0.001 | CK, U/L | | | <0.001 | CKMB, ng/mL | | | <0.001 | hsTn T, ng/L | | | <0.001 | NT-proBNP, pg/mL | | | <0.001 | LP(a), mg/L | | | 0.019 |
|
|
Abbreviations: STEMI: ST-Segment elevation myocardial infarction; WBC: white blood cell; hs-CRP: high-sensitivity C-reactive protein; HDL-C: high-density lipoprotein-cholesterol; LDL: low-density lipoprotein-cholesterol; LDH: lactate dehydrogenase; CK: creatine kinase; CKMB: creatine kinase MB; hsTn T: hypersensitive troponin T; NT-proBNP: N-terminal probrain natriuretic peptide; Lp(a): lipoprotein-a.
|